Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes

Early in the SARS-CoV-2 pandemic, convalescent plasma (CP) therapy was proposed as a treatment for severely ill patients. We conducted a CP treatment protocol under the Mayo Clinic Extended Access Program at University Hospital Brooklyn (UHB). Potential donors were screened with a lateral flow assay...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hum Immunol
Hauptverfasser: Mendoza, Rachelle P., Fyke, William, Daniel, David, Gabutan, Elmer, Das, Ballabh, Bajaj, Harsha, Easy, Maxine, Vasileva, Ana, Colbourn, Robert, Alawad, Mouyed, Dehghani, Amir, Lin, Bo, Emechebe, Dokpe, Patel, Purvi, Jabbar, Absia, Nikolov, Dimitar B., Giovaniello, Dominick, Kang, Steven, Tatem, Luis, Bromberg, Kenneth, Augenbraun, Michael, Premsrirut, Prem, Libien, Jenny, Norin, Allen J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics. 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885628/
https://ncbi.nlm.nih.gov/pubmed/33640208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humimm.2021.02.007
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge